Fulgent Genetics Statistics
NASDAQ: FLGTHealth CareMedical SpecialitiesUSD
24.12-0.66 (-2.66%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Fulgent Genetics by the numbers
Fulgent Genetics has a market capitalization of $673.9 million based on 27.94M shares outstanding. With trailing EPS of $-3.10, Fulgent Genetics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.5% above its 50-day average and 26.2% above its 200-day average.
Average daily trading volume is 330.28K shares, or about $8.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
FLGT valuation vs. peer median
| Metric | FLGT | Peer median | Difference |
|---|---|---|---|
| Market cap | $673.89M | $141.39M | +377% |
| Avg. volume | 330.28K | 312.33K | +6% |
Peer median across 8 companies: YDES, CSTL, FRNM, TLSI, BNR, KEQU, XGN, BDSX.
Valuation
- Market cap
- $673.89M
- Price / sales (latest FY)
- 2.09
- EPS (TTM)
- $-3.10
- Shares outstanding
- 27.94M
Price and trading
- Previous close
- 24.78
- Open
- 24.12
- Day range
- 23.88 – 24.79
- 52-week range
- 13.46 – 31.04
- 52-week change
- -19.60%
- Beta
- —
- Volume
- 322.97K
- Average volume
- 330.28K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 673.89M
- Forward Pe
- -17.74
- Eps
- -3.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 31.04
- Week52 Low
- 13.46
- Avg Volume
- 330.28K
- Shares Outstanding
- 27.94M
- Ma50
- 21.82
- Ma200
- 19.11
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -22.29%
- Pct From52w Low
- 79.20%